Cargando…

The Impact of the SARS-CoV-2 Pandemic in PID Patients Receiving Ig Replacement Therapy

Detalles Bibliográficos
Autores principales:	Cekic, Sukru, Cicek, Fatih, Kilic, Sara Sebnem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810283/ https://www.ncbi.nlm.nih.gov/pubmed/33452597 http://dx.doi.org/10.1007/s10875-020-00958-5

Ejemplares similares

The Impact of the COVID-19 Pandemic in Adolescents with Asthma
por: Cekic, Sukru, et al.
Publicado: (2021)

SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on
por: Korte, Wolfgang, et al.
Publicado: (2021)

Cross-reactions between rheumatoid factor and IgM SARS-CoV-2()
por: Vinyé Bausà, Marta, et al.
Publicado: (2020)

Salivary IgAs and Their Role in Mucosal Neutralization of SARS-CoV-2 Variants of Concern
por: Diem, Gabriel, et al.
Publicado: (2022)

Outcome of patients receiving V-V ECMO for SARS-CoV-2 severe acute respiratory failure
por: Morris, I.S., et al.
Publicado: (2023)

SARS-COV-2 IgG and IgM Antibodies in Cancer Patients
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

High SARS-CoV-2 IgG seroprevalence among pregnant Cameroun women 14 months after the beginning of the pandemic
por: Mansuy, J.-M., et al.
Publicado: (2022)

Reactivation of Strongyloides stercoralis in patients with SARS-CoV-2 pneumonia receiving dexamethasone()
por: Feria, Lucia, et al.
Publicado: (2022)

Methodologies of COLDICE and Cryo-PID studies: details make the difference
por: Lau, Edmund M. T., et al.
Publicado: (2020)

Research during the SARS-CoV-2 pandemic()
por: Muñoz de Nova, José Luis, et al.
Publicado: (2021)

Emerging complexities of SARS-CoV-2 pandemic
por: Gupta, Harish
Publicado: (2021)

Kinetics of SARS-CoV-2 specific antibodies (IgM, IgA, IgG) in non-hospitalized patients four months following infection
por: Orth-Höller, Dorothea, et al.
Publicado: (2021)

Kinetics and performance of the Abbott architect SARS-CoV-2 IgG antibody assay
por: Hamilton, Fergus, et al.
Publicado: (2020)

Persistence of anti-SARS-CoV-2 IgM in convalescent COVID-19 patients
por: Yan, Xiquan, et al.
Publicado: (2021)

Gross hematuria following SARS-CoV-2 vaccination in patients with IgA nephropathy
por: Perrin, Peggy, et al.
Publicado: (2021)

May IgG4-related disease be reactivated by SARS-CoV-2 infection?
por: Kobak, Senol
Publicado: (2022)

SARS CoV-2 genetic jump to a new SARS CoV-3 pandemic: Let’s be prepared
por: Kelleni, Mina T.
Publicado: (2023)

Nasopharyngeal swabs during SARS-CoV-2 pandemic: a role for the otolaryngologist
por: Tagliabue, Marta, et al.
Publicado: (2020)

Anti-SARS-CoV-2 IgG antibodies in patients with or without SARS-CoV-2 infection after BNT162b2 vaccine booster
por: Salvagno, G.L., et al.
Publicado: (2022)

The future of neurorehabilitation after the SARS-CoV-2 pandemic()
por: Juárez-Belaúnde, A., et al.
Publicado: (2020)

Omicron variant in the current SARS-CoV-2 pandemic
por: Nasiri, Kaveh, et al.
Publicado: (2022)

Managing halitosis during the SARS-CoV-2 pandemic
por: Nasiri, Kaveh, et al.
Publicado: (2022)

Impact of Sars‐CoV‐2 pandemic on psoriatic patients
por: Biondi, Gabriele, et al.
Publicado: (2022)

Patients with Common Cold Coronaviruses Tested Negative for IgG Antibody to SARS-CoV-2
por: Brecher, Stephen M., et al.
Publicado: (2020)

What is the long‐term clinical significance of anti‐SARS‐CoV‐2‐specific IgG?
por: Alberca, Gabriela Gama Freire, et al.
Publicado: (2020)

De novo IgA vasculitis following adenovirus-based SARS-CoV-2 vaccination
por: Oniszczuk, Julie, et al.
Publicado: (2021)

Decline of SARS-CoV-2-specific IgG, IgM and IgA in convalescent COVID-19 patients within 100 days after hospital discharge
por: Ma, Huan, et al.
Publicado: (2020)

The Effect of Allergen Immunotherapy on the Development of New Sensitization in Children
por: Şükrü, Çekiç, et al.
Publicado: (2021)

Plitidepsin for the management of a cancer patient infected with SARS-CoV-2 while receiving chemotherapy
por: Guisado-Vasco, P., et al.
Publicado: (2021)

Response to the comments received on a case report SARS-CoV-2 viral sepsis with meningoencephalitis
por: Dharsandiya, Mitkumar, et al.
Publicado: (2021)

Reliability and usefulness of a rapid IgM‐IgG antibody test for the diagnosis of SARS-CoV-2 infection: A preliminary report.
por: Spicuzza, Lucia, et al.
Publicado: (2020)

Re-evaluating positive serum samples for SARS-CoV-2-specific IgA and IgG antibodies using an in-house serological assay
por: Cacaci, Margherita, et al.
Publicado: (2021)

Evaluation of Performance of the BD Veritor SARS-CoV-2 Chromatographic Immunoassay Test in Patients with Symptoms of COVID-19
por: Kilic, Abdullah, et al.
Publicado: (2021)

The role of povidone-iodine in managing of SARS-CoV-2 pandemic
por: Nasiri, Kaveh, et al.
Publicado: (2022)

White coat hypertension during the SARS-CoV-2 pandemic
por: Nasiri, Kaveh, et al.
Publicado: (2023)

Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients
por: Lee, Yu-Lin, et al.
Publicado: (2020)

Anti-GBM nephritis with mesangial IgA deposits after SARS-CoV-2 mRNA vaccination
por: Sacker, Allan, et al.
Publicado: (2021)

A case of gross hematuria and IgA nephropathy flare-up following SARS-CoV-2 vaccination
por: Rahim, Shab E Gul, et al.
Publicado: (2021)

Humoral immune durability of IgG for anti-SARS-CoV-2 in the normal pregnant women in Wuhan, China
por: Ma, Hongwen, et al.
Publicado: (2021)

Evaluation of Specific IgG Antibody in Subjects Who Had Been Previously Infected with SARS-CoV-2
por: Rostami, Soodabeh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_eldtsf8gvb2uahkas4jnqfbkal